Concepedia

Samuel V. Calzadilla

SV

9

Publications

503

Citations

9

H-Index

1978

Active since

Affiliations

Abbott Fund(Current)

Abbott (United Kingdom)

Samuel V. Calzadilla is an author at Abbott Fund specializing in physiology, medicine, and pharmacology.

Top concepts

Publications per year

1978–2004

9

Publications

9

Pharmacological characterization of A-127722: an orally active and highly potent ETA-selective receptor antagonist.

Terry J. Opgenorth, Andrew Adler, Samuel V. Calzadilla et al. · Journal of Pharmacology and Experimental Therapeutics · 1996 · 209 citations

ABT-627, an endothelin ETA receptor-selective antagonist, attenuates tactile allodynia in a diabetic rat model of neuropathic pain

Michael F. Jarvis, Jerry L. Wessale, Chang Zhu et al. · European Journal of Pharmacology · 2000 · 97 citations

, , +11

Pharmacology of endothelin receptor antagonists ABT-627, ABT-546, A-182086 and A-192621: <i>ex vivo</i> and <i>in vivo</i> studies

Jerry L. Wessale, Andrew Adler, Eugene I. Novosad et al. · Clinical Science · 2002 · 61 citations

Azole Endothelin Antagonists. 3. Using Δ log <i>P</i> as a Tool To Improve Absorption

Thomas W von Geldern, Daniël J. Hoffman, Jeffrey A. Kester et al. · Journal of Medicinal Chemistry · 1996 · 35 citations · Full text

Effects of Endothelin Receptor Antagonists on the Plasma Immunoreactive Endothelin-1 Level

Terry J. Opgenorth, Jerry L. Wessale, Douglas B. Dixon et al. · Journal of Cardiovascular Pharmacology · 2000 · 31 citations

, , +12

Rows per page

1–5 of 9